BRIEF-Celgene To Acquire Remaining Shares Of Juno Therapeutics For $87 Per Share By: Reuters: Company News January 22, 2018 at 06:36 AM EST * CELGENE CORPORATION TO ACQUIRE JUNO THERAPEUTICS, INC., ADVANCING GLOBAL LEADERSHIP IN CELLULAR IMMUNOTHERAPY Read More >> Related Stocks: Celgene Corp